2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Overactive Bladder Syndrome: new trials by email Literature Review of Overactive Bladder Syndrome trials Research Report on Overactive Bladder Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome MitoQ (mitoquinol mesylate), Placebo - Lower Urinary Tract Symptoms, Overactive Bladder Syndrome | Phase 2 | Terminated | Iman Al-Naggar, PhD | 20 | 2024-04-03 | 2026-05-01 |
| Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity AV608 - Overactive Bladder Syndrome | Phase 2 | Terminated | Avera Pharmaceuticals | 62 | 2006-06-01 | 2008-02-25 |
Lower Urinary Tract Symptoms (1) · Metabolic Syndrome (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence, Urge (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urological Manifestations (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Lower Urinary Tract Symptoms (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Urinary Bladder Diseases (1) · Urinary Incontinence (1) · Urination Disorders (1)
mitoquinone (1)
Avera Pharmaceuticals (1) · Iman Al-Naggar, PhD (1)
Netherlands (1) · United Kingdom (1) · United States (1)
Iman M Al-Naggar, PhD (1) · Joao Siffert, MD (1) · Linda Cardozo, MD FRCOG (1)
P30AG067988 (1)